Chronic obstructive pulmonary disease: Evidence for an autoimmune component

Cellular and Molecular Immunology

Volumn 6, Issue 2, 2009, Pages 81-86

  Stefanska, Anna M ^a   Walsh, Patrick T ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Autoimmunity; COPD; Emphysema; Th1; Th17

Indexed keywords

BRONCHODILATING AGENT; PROTEINASE INHIBITOR; TOBACCO SMOKE; AUTACOID; AUTOANTIGEN; REACTIVE OXYGEN METABOLITE; CORTICOSTEROID; CYTOKINE; LONG ACTING DRUG;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; EXTRACELLULAR MATRIX; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG EMPHYSEMA; PATHOPHYSIOLOGY; RESPIRATORY EPITHELIUM; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; ANIMAL; ENZYMOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PROTEIN PROCESSING; RESPIRATORY TRACT MUCOSA; SMOKING; ASTHMA; AUTOIMMUNE DISEASE; CELL INTERACTION; CELLULAR IMMUNITY; CIGARETTE SMOKING; DISEASE EXACERBATION; EMPHYSEMA; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; LUNG CANCER; LUNG INFECTION; MORTALITY; MUCOCILIARY CLEARANCE; RESPIRATORY TRACT INFLAMMATION; RISK FACTOR; SYMPTOM; T LYMPHOCYTE;

NICOTIANA TABACUM;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; EXTRACELLULAR MATRIX; HUMANS; IMMUNOSUPPRESSION; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; REACTIVE OXYGEN SPECIES; RESPIRATORY MUCOSA; SELF TOLERANCE; SMOKING;

EID: 68549115484     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2009.11     Document Type: Review

References (48)

1. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364:613-620. (Pubitemid 39094180)
2. Cosio MG, Guerassimov A. Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma. Am J Respir Crit Care Med. 1999;160:S21-25.
3. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8:183-192. (Pubitemid 351323287)
4. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22:672-688. (Pubitemid 37258549)
5. Quint JK, Wedzicha JA. The neutrophil in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2007;119:1065-1071. (Pubitemid 46654162)
6. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:S29-32.
7. Tetley TD. Macrophages and the pathogenesis of COPD. Chest. 2002;121:156S-159S.
8. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1:1645-1648. (Pubitemid 8124466)
9. Simmons MS, Connett JE, Nides MA, et al. Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study. Eur Respir J. 2005;25:1011-1017.
10. Bals R, Hiemstra PS. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J. 2004;23:327-333. (Pubitemid 38195522)
11. Hiemstra PS, Bals R. Series introduction: Innate host defense of the respiratory epithelium. J Leukoc Biol. 2004;75:3-4. (Pubitemid 38166773)
12. Mehta H, Nazzal K, Sadikot RT. Cigarette smoking and innate immunity. Inflamm Res. 2008;57:497-503.
13. Araya J, Cambier S, Markovics JA, et al. Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. J Clin Invest. 2007;117:3551-3562. (Pubitemid 350097010)
14. Morris DG, Huang X, Kaminski N, et al. Loss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysema. Nature. 2003;422:169-173. (Pubitemid 36362749)
15. Mio T, Romberger DJ, Thompson AB, Robbins RA, Heires A, Rennard SI. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med. 1997;155:1770-1776. (Pubitemid 27216691)
16. Iwamura C, Nakayama T. Toll-like receptors in the respiratory system: their roles in inflammation. Curr Allergy Asthma Rep. 2008;8:7-13.
17. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med. 1995;152:1666-1672.
18. Russell RE, Thorley A, Culpitt SV, et al. Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol. 2002;283:L867-873. (Pubitemid 35052682)
19. Culpitt SV, Rogers DF, Shah P, et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167:24-31. (Pubitemid 36015913)
20. Saetta M, Mariani M, Panina-Bordignon P, et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;165:1404-1409. (Pubitemid 34522945)
21. Grumelli S, Corry DB, Song LZ, et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med. 2004;1:e8. (Pubitemid 40412702)
22. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
23. Tsoumakidou M, Demedts IK, Brusselle GG, Jeffery PK. Dendritic cells in chronic obstructive pulmonary disease: new players in an old game. Am J Respir Crit Care Med. 2008;177:1180-1186. (Pubitemid 351860925)
24. Robbins CS, Dawe DE, Goncharova SI, et al. Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol. 2004;30:202-211.
25. Robbins CS, Franco F, Mouded M, Cernadas M, Shapiro SD. Cigarette smoke exposure impairs dendritic cell maturation and T cell proliferation in thoracic lymph nodes of mice. J Immunol. 2008;180:6623-6628.
26. D'Hulst A I, Vermaelen KY, Brusselle GG, Joos GF, Pauwels RA. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J. 2005;26:204-213.
27. Tsoumakidou M, Elston W, Zhu J, et al. Cigarette smoking alters bronchial mucosal immunity in asthma. Am J Respir Crit Care Med. 2007;175:919-925. (Pubitemid 46684702)
28. Demedts IK, Bracke KR, Van Pottelberge G, et al. Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:998-1005. (Pubitemid 46741751)
29. Bracke KR, D'Hulst A I, Maes T, et al. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J Immunol. 2006;177:4350-4359. (Pubitemid 44469763)
30. Bracke K, Cataldo D, Maes T, et al. Matrix metalloproteinase-12 and cathepsin D expression in pulmonary macrophages and dendritic cells of cigarette smoke-exposed mice. Int Arch Allergy Immunol. 2005;138:169-179. (Pubitemid 41540674)
31. Saetta M, Di Stefano A, Turato G, et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:822-826. (Pubitemid 28150694)
32. Motz GT, Eppert BL, Sun G, et al. Persistence of lung CD8 T cell oligoclonal expansions upon smoking cessation in a mouse model of cigarette smoke-induced emphysema. J Immunol. 2008;181:8036-8043.
33. Korn S, Wiewrodt R, Walz YC, et al. Characterization of the interstitial lung and peripheral blood T cell receptor repertoire in cigarette smokers. Am J Respir Cell Mol Biol. 2005;32:142-148. (Pubitemid 40189696)
34. O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med. 1997;155:852-857.
35. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J. 2001;17:946-953. (Pubitemid 32600344)
36. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med. 2001;163:737-744. (Pubitemid 32230838)
37. Hodge G, Nairn J, Holmes M, Reynolds PN, Hodge S. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects. Clin Exp Immunol. 2007;150:22-29. (Pubitemid 47383287)
38. Miotto D, Ruggieri MP, Boschetto P, et al. Interleukin-13 and -4 expression in the central airways of smokers with chronic bronchitis. Eur Respir J. 2003;22:602-608. (Pubitemid 37258537)
39. Wang Z, Zheng T, Zhu Z, et al. Interferon γ induction of pulmonary emphysema in the adult murine lung. J Exp Med. 2000;192:1587-1600.
40. + Th17 type cells associated with chronic cigarette smoke induced airspace enlargement. Immunol Lett. 2008;121:13-21.
41. Prause O, Bozinovski S, Anderson GP, Linden A. Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. Thorax. 2004;59:313-317. (Pubitemid 38496749)
42. Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, Wu R. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem. 2003;278:17036-17043. (Pubitemid 36799579)
43. Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med. 2007;13:567-569. (Pubitemid 46828488)
44. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2645-2653. (Pubitemid 38787999)
45. Gosman MM, Willemse BW, Jansen DF, et al. Increased number of B-cells in bronchial biopsies in COPD. Eur Respir J. 2006;27:60-64.
46. van der Strate BW, Postma DS, Brandsma CA, et al. Cigarette smoke-induced emphysema: A role for the B cell? Am J Respir Crit Care Med. 2006;173:751-758.
47. Feghali-Bostwick CA, Gadgil AS, Otterbein LE, et al. Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177:156-163.
48. Keating GM, McCormack PL. Salmeterol/fluticasone propionate: a review of its use in the treatment of chronic obstructive pulmonary disease. Drugs. 2007;67:2383-2405. (Pubitemid 350080283)